NO942396L - Preparat med vedvarende frigiving av anti-endotelin substans - Google Patents

Preparat med vedvarende frigiving av anti-endotelin substans

Info

Publication number
NO942396L
NO942396L NO942396A NO942396A NO942396L NO 942396 L NO942396 L NO 942396L NO 942396 A NO942396 A NO 942396A NO 942396 A NO942396 A NO 942396A NO 942396 L NO942396 L NO 942396L
Authority
NO
Norway
Prior art keywords
endothelin
substance
continuous release
endothelin substance
sustained
Prior art date
Application number
NO942396A
Other languages
English (en)
Other versions
NO942396D0 (no
Inventor
Yasutaka Igari
Hitoshi Ikeda
Masao Tsuda
Kazumichi Yamamoto
Mitsuhiro Wakimasu
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO942396D0 publication Critical patent/NO942396D0/no
Publication of NO942396L publication Critical patent/NO942396L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Preparat med vedvarende frigiving inneholdende en antl- endotellnsubstans og en bionedbrytbar polymer. Preparatet med vedvarende frigiving ifølge oppfinnelsen frigjør en anti-endotelinsubstans, og fungerer godt i behandling av endotelin-assosierte sykdommer.
NO942396A 1993-06-24 1994-06-23 Preparat med vedvarende frigiving av anti-endotelin substans NO942396L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15339393 1993-06-24

Publications (2)

Publication Number Publication Date
NO942396D0 NO942396D0 (no) 1994-06-23
NO942396L true NO942396L (no) 1994-12-27

Family

ID=15561515

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942396A NO942396L (no) 1993-06-24 1994-06-23 Preparat med vedvarende frigiving av anti-endotelin substans

Country Status (6)

Country Link
EP (1) EP0647449A1 (no)
KR (1) KR950000167A (no)
CN (1) CN1109780A (no)
CA (1) CA2126619A1 (no)
FI (1) FI943071A (no)
NO (1) NO942396L (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087324A (en) 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
ATE197398T1 (de) * 1994-09-09 2000-11-11 Takeda Chemical Industries Ltd Zubereitung mit verzögerter freigabe eines metallsalz eines peptids
US5573762A (en) * 1995-04-24 1996-11-12 Genentech, Inc. Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
EP0815870A3 (en) * 1996-06-27 2000-05-03 Takeda Chemical Industries, Ltd. Composition for prohylaxis or treatment of cerebral infarction
AU4196697A (en) * 1996-09-16 1998-04-14 Dalhousie University Use of igf-i for the treatment of polycystic kidney disease and related indications
AU6366999A (en) * 1998-10-30 2000-05-22 Takeda Chemical Industries Ltd. Betacellulin protein-containing preparations
AUPP785098A0 (en) 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
EP1277787A4 (en) * 2000-04-28 2009-11-11 Mitsubishi Tanabe Pharma Corp PROCESS FOR PREPARING A MICROSPHERE
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
JP2004331750A (ja) 2003-05-02 2004-11-25 Canon Inc ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
US20070213264A1 (en) 2005-12-02 2007-09-13 Mingdong Zhou Neuregulin variants and methods of screening and using thereof
EP1981525B1 (en) 2005-12-30 2015-01-21 Zensun (Shanghai) Science and Technology Limited Extended release of neuregulin for improved cardiac function
EP2190433A2 (en) 2007-08-22 2010-06-02 Gilead Colorado, Inc. Therapy for complications of diabetes
US20090156488A1 (en) 2007-09-12 2009-06-18 Zensun (Shanghai) Science & Technology Limited Use of neuregulin for organ preservation
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
CN105611955A (zh) 2013-05-22 2016-05-25 上海泽生科技开发有限公司 缓释纽兰格林治疗心力衰竭

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103857T3 (es) * 1991-08-13 1997-10-01 Takeda Chemical Industries Ltd Peptidos ciclicos y su uso.
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.

Also Published As

Publication number Publication date
FI943071A (fi) 1994-12-25
CA2126619A1 (en) 1994-12-25
NO942396D0 (no) 1994-06-23
EP0647449A1 (en) 1995-04-12
CN1109780A (zh) 1995-10-11
KR950000167A (ko) 1995-01-03
FI943071A0 (fi) 1994-06-23

Similar Documents

Publication Publication Date Title
NO942396L (no) Preparat med vedvarende frigiving av anti-endotelin substans
NO962088D0 (no) Preparat for in vivo-produksjon av terapeutiske produkter
ATE417604T1 (de) Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ES2118251T3 (es) Preparaciones de microparticulas a base de copolimeros biologicamente degradables.
PT839525E (pt) Preparacao de libertacao prolongada
FI972964A (fi) Biohajoavia polymeereja, menetelmiä niiden valmistamiseksi ja niiden käyttö biohajoavien muovaustuotteiden valmistamiseen
MY107500A (en) Preparation process of sustained release compositions and the compositions thus obtained
PT841903E (pt) Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida
TR199701260T1 (xx) �nsan�n cinsel tepkisini mod�lasyonu i�in y�ntem ve form�lasyonlar.
HUP0002935A2 (hu) Gyomorban visszatartott, szabályozott hatóanyag kibocsátású mikrogömböcskék javított gyógyszeradagolás elősegítésére
DE59608732D1 (de) Lagerstabile arzneiformen
ATE232396T1 (de) Oxydiertes thymosin beta 4
NO994165D0 (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
TR28109A (tr) Duman halinde dezenfekte eden formülasyonlar.
IS5366A (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
NO980296D0 (no) Forbedrede terapeutiske midler
DE69627365D1 (de) Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
ATE236621T1 (de) Niedrig dosierte tabletten, und verfahren zur herstellung
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
EP0480391A3 (en) Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
NO911298D0 (no) Farmasoeytisk preparat og anvendelse derav.
NO304648B1 (no) (S)-alfa-fenyl-2-pyridinetanaminbenzoat, farmasoeytisk preparat inneholdende denne forbindelsen og dens anvendelse til fremstilling av legemiddel